Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's Revision label was updated from v3.6.3 to v3.6.4, reflecting a minor update to the page's revision history.SummaryDifference0.0%

- Check17 days agoChange DetectedAdds a publication title related to the EV-202 study, the sponsor organization, and a 'Helpful Links Provided by' label, representing additional contextual metadata at the bottom of the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision line was updated from v3.6.2 to v3.6.3, reflecting a newer document revision. This is a metadata update and does not change substantive content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page revision metadata was updated from v3.6.0 to v3.6.2. This indicates a minor software update to the site.SummaryDifference0.0%

- Check46 days agoChange DetectedNew study record date entries were added (2026-06-16, 2026-06-12, 2026-06) and older entries (2026-04-13, 2026-03-24, 2026-03) were removed, reflecting updates to the study's record log.SummaryDifference0.1%

- Check53 days agoChange DetectedRecruitment status note 'No longer looking for participants' was added to the page, signaling that enrollment is closed. The header formatting for the Interventions section was adjusted, and a new version stamp (Revision: v3.6.0) along with updated navigation/help sections were introduced.SummaryDifference0.3%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.